Beijing Tongrentang Co., Ltd (SHA:600085)

Market Cap	40.95B -18.7%
Revenue (ttm)	18.09B +0.7%
Net Income	1.35B -16.9%
EPS	0.99 -16.8%
Shares Out	1.37B
PE Ratio	30.23
Forward PE	23.51
Dividend	1.00 (3.33%)
Ex-Dividend Date	n/a

Volume	4,860,032
Average Volume	5,706,095
Open	29.80
Previous Close	29.86
Day's Range	29.65 - 29.98
52-Week Range	29.60 - 38.36
Beta	0.19
RSI	39.95
Earnings Date	Mar 31, 2026

About Beijing Tongrentang

Beijing Tongrentang Co., Ltd engages in the research, production, distribution, and sale of Chinese patent medicines in China and internationally. It operates through the Company, Science Company, Commerce Company, and Others segments. The company offers various product dosage forms, such as pills, powders, alcoholic preparations, capsules, oral liquids, and dripping pills. Its products are used for cardiovascular, gynecology, heat-clearing, respiratory system, nourishing and calming, digestive system, pediatrics, wind and dampness-removing, or...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 17,883
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600085

Financial Performance

In 2024, Beijing Tongrentang's revenue was 18.60 billion, an increase of 4.12% compared to the previous year's 17.86 billion. Earnings were 1.53 billion, a decrease of -8.54%.